Study tracks outcomes in men with inherited prostate cancer risks
Part of Cancer, Digestive system, Genetic & congenital, Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at how prostate cancer diagnoses and treatments turn out over time. It compares men who carry rare inherited gene changes that raise prostate cancer risk with men who do not, to better understand which treatments and outcomes may differ.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man diagnosed with prostate cancer
- You know your inherited (germline) genetic status for certain prostate-cancer–risk genes
- Either you carry one of these rare gene changes or you are confirmed not to carry them
- You must be age 18 or older
- You can give informed consent and your medical information can be followed for at least 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This trial studies how well “active surveillance” works for men with prostate cancer who are considered higher risk because of family history or genetics. It aims to safely monitor the cancer and decide the best timing for treatment if needed, while tracking side effects and follow-up success.
This study tries to personalize prostate cancer care by matching treatment decisions to a person’s specific risk profile. You might be able to join if you have certain types of prostate cancer or a strong family history and meet health-function requirements.
This study looks at how patients and doctors feel about genetic testing for prostate cancer. It aims to improve how genetic risk information is shared and understood.
This is a study that looks at how prostate cancer runs in families and what genetic factors may be involved. It may help researchers better understand hereditary risk, whether you have prostate cancer or are a family member without it.
This study looks at how prostate cancer shows up on scans and how those imaging findings relate to treatment and outcomes. It may help doctors better predict risk and guide care, especially for people with higher risk or early or suspected prostate cancer.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.